Text Size

Clinical Trials for Comparison of Two Kinds of Moxibustion

The recruitment status of this study is unknown because the information has not been verified recently.
Verified April 2010 by Semyung University.
Recruitment status was  Recruiting
Sponsor:
Collaborator:
Kyunghee University
Information provided by:
Semyung University
ClinicalTrials.gov Identifier:
NCT01366456
First received: June 2, 2011
Last updated: June 8, 2011
Last verified: April 2010
History of Changes
  Purpose

The purpose of this study is to evaluate efficacy of Shingigu and Charcoal moxibustion scientifically and objectively.


Condition Intervention
Temperature Change
 Device: Moxibustion

Study Type: Interventional
Study Design: Allocation: Randomized
Endpoint Classification: Safety/Efficacy Study
Intervention Model: Crossover Assignment
Masking: Double Blind (Subject, Outcomes Assessor)
Official Title: Clinical Trials for Comparison Between Shingigu and Charcoal Moxa on CV-12

Resource links provided by NLM:

U.S. FDA Resources

Further study details as provided by Semyung University:

Primary Outcome Measures:
  • Temperature Change after moxa treatment [ Time Frame: 30 minutes after treatment ] [ Designated as safety issue: No ]

Estimated Enrollment: 40
Study Start Date: June 2011
Estimated Study Completion Date: June 2012
Estimated Primary Completion Date: June 2012 (Final data collection date for primary outcome measure)
Arms Assigned Interventions
Active Comparator: Shingigu
Treat with Shingigu
 Device: Moxibustion
Comparison of different kinds of moxibustion
Active Comparator: Charcoal
Treat with Charcoal
 Device: Moxibustion
Comparison of different kinds of moxibustion

Detailed Description:

Moxibustion is traditional treatment that regulate circulation of Qi-blood by making the body warm to prevent and treat disease. Recently many kinds of moxibustion and moxibustion apparatus were developed. However evaluating efficacy of moxibustion is insufficient. Thus, there is need for objective evaluating about efficacy of moxibustion.

  Eligibility

Ages Eligible for Study:   18 Years to 65 Years
Genders Eligible for Study:   Both
Accepts Healthy Volunteers:   Yes
Criteria

Inclusion Criteria:

  • 18~65 years old

Exclusion Criteria:

  • Hyperthyroidism
  • Heart disease(Heart failure, angina pectoris, myocardial infarction)
  • Uncontrolled hypertension (SBP>145mmHg or DBP>95mmHg)
  • Severe renal disorder
  • Severe liver disorder
  • Diabetes Mellitus
  • Female are in the duration of pregnancy
  Contacts and Locations
Please refer to this study by its ClinicalTrials.gov identifier: NCT01366456

Locations
Korea, Republic of
Semyung University Chungju Hospital Recruiting
Chungju, Chungbuk, Korea, Republic of, 380-960
Contact: Hoyeon Go, O.M.D.     821047540955     kohoyeon@gmail.com    
Sponsors and Collaborators
Semyung University
Kyunghee University
Investigators
Principal Investigator: Hoyeon Go, O.M.D. Semyung University Chungju Hospital
  More Information

No publications provided

Responsible Party: Hoyeon Go, Semyung University
ClinicalTrials.gov Identifier: NCT01366456     History of Changes
Other Study ID Numbers: SMCOH-IM01
Study First Received: June 2, 2011
Last Updated: June 8, 2011
Health Authority: Korea: Institutional Review Board

Keywords provided by Semyung University:
Temperature Change
Moxibustion
Warming effect

Additional relevant MeSH terms:
Charcoal
Antidotes
Protective Agents
Physiological Effects of Drugs
Pharmacologic Actions

ClinicalTrials.gov processed this record on May 23, 2013